trifluperidol has been researched along with Brain Damage, Chronic in 2 studies
Trifluperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p621)
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campbell, M | 1 |
Fish, B | 1 |
Shapiro, T | 1 |
Floyd, A | 1 |
Le Vann, LJ | 1 |
1 trial available for trifluperidol and Brain Damage, Chronic
Article | Year |
---|---|
Thiothixene in young disturbed children. A pilot study.
Topics: Brain Damage, Chronic; Child; Child, Preschool; Chlorpromazine; Humans; Intellectual Disability; Sch | 1970 |
1 other study available for trifluperidol and Brain Damage, Chronic
Article | Year |
---|---|
A new butyrophenone: trifluperidol. A psychiatric evaluation in a pediatric setting.
Topics: Adolescent; Antidepressive Agents; Aspartate Aminotransferases; Attention; Brain Damage, Chronic; Bu | 1968 |